NCT03031405

Brief Summary

The purpose of the study is to examine whether oxytocin and oxytocin receptor gene polymorphism affect the development of intrusive memories, a cardinal symptom of PTSD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
220

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2017

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

January 18, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 25, 2017

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2018

Completed
Last Updated

August 21, 2018

Status Verified

January 1, 2017

Enrollment Period

1.5 years

First QC Date

January 18, 2017

Last Update Submit

August 19, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Intrusive memories

    Influence of oxytocin on the development of intrusive memories measured with an intrusion diary

    four consecutive days

Secondary Outcomes (3)

  • Noradrenergic System (measured with salivary alpha-amylase - u/ml)

    Day 1

  • Genetic polymorphism

    four consecutive days

  • Hypothalamic-pituitary-adrenal (HPA) axis (measured with salivary cortisol - nmol/L)

    Day 1

Study Arms (2)

Oxytocin and trauma film paradigm

EXPERIMENTAL
Drug: Oxytocin nasal spray

Placebo and trauma film paradigm

PLACEBO COMPARATOR
Drug: Placebos

Interventions

Oxytocin and trauma film paradigm

Placebo nasal spray

Placebo and trauma film paradigm

Eligibility Criteria

Age18 Years - 44 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy female volunteers
  • German on a native level

You may not qualify if:

  • former or present disorder according to the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5)
  • any physical illnesses
  • any medication intake (except oral contraceptive)
  • history of traumatic experience, e.g. history of sexual abuse or rape
  • pregnancy or lactation period
  • follicular phase of menstrual cycle for all women not using oral contraceptives

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin

Berlin, 12203, Germany

Location

Related Publications (1)

  • Schultebraucks K, Maslahati T, Wingenfeld K, Hellmann-Regen J, Kraft J, Kownatzki M, Behnia B, Ripke S, Otte C, Roepke S. Intranasal oxytocin administration impacts the acquisition and consolidation of trauma-associated memories: a double-blind randomized placebo-controlled experimental study in healthy women. Neuropsychopharmacology. 2022 Apr;47(5):1046-1054. doi: 10.1038/s41386-021-01247-4. Epub 2021 Dec 9.

Study Officials

  • Stefan Roepke, PD Dr.

    Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

January 18, 2017

First Posted

January 25, 2017

Study Start

January 15, 2017

Primary Completion

June 30, 2018

Study Completion

June 30, 2018

Last Updated

August 21, 2018

Record last verified: 2017-01

Locations